SCHEMBL4029613

SCHEMBL4029613

Cn1c(-c2sccc2NC(=O)NCc2ccccc2Cl)nc(C(=O)O)c(O)c1=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC1 P07992 1/20 0.47
FEN1 P39748 1/20 0.47
ERCC4 Q92889 1/20 0.47
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KMT2A Q03164 2/20 0.41
NPC1 O15118 2/20 0.41
MEN1 O00255 1/20 0.41
ROCK2 O75116 1/20 0.40
ROCK1 Q13464 1/20 0.40
THRB P10828 1/20 0.40
RAB9A P51151 1/20 0.40
MAPK8 P45983 1/20 0.40
MAPK10 P53779 1/20 0.40
PTGER3 P43115 3/20 0.39
P2RX7 Q99572 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4027671 0.86 ERCC1 (0.47) ERCC1FEN1ERCC4NPC1THRB
SCHEMBL4028367 0.86 ERCC1 (0.47) ERCC1FEN1ERCC4SMN1; SMN2KMT2A
SCHEMBL4027570 0.84 ERCC1 (0.55) ERCC1FEN1ERCC4ALDH1A1MAPK1
SCHEMBL4028018 0.83 ERCC1 (0.49) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL4026082 0.83 ERCC1 (0.46) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL4028503 0.82 ERCC1 (0.46) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL3836880 0.81 RAB9A (0.43) KDM4EALDH1A1MAPK1SMN1; SMN2KMT2A
SCHEMBL4028016 0.80 FEN1 (0.58) ERCC1FEN1ERCC4ALDH1A1MAPK8
SCHEMBL4030403 0.79 ERCC1 (0.56) ERCC1FEN1ERCC4KMT2ANPC1
SCHEMBL4030887 0.79 ERCC1 (0.51) ERCC1FEN1ERCC4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1470113-B1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2009-01-07 EP claimed
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2005-06-16 US claimed
EP-1470113-B1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2009-01-07 EP disclosed
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors POLR2A, POLR1E, POLR2E ERCC1 3181/4885FEN1 343/4885ERCC4 1663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.